Susanna Ulahannan to Combined Modality Therapy
This is a "connection" page, showing publications Susanna Ulahannan has written about Combined Modality Therapy.
Connection Strength
0.063
-
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma. J Hepatol. 2017 03; 66(3):545-551.
Score: 0.032
-
Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancer. Int J Cancer. 2016 10 01; 139(7):1648-57.
Score: 0.031